Hitek Global Inc., through its subsidiaries, provides information technology (IT) consulting and solutions services to small and medium, and large businesses in China.
FAIL · Does not pass the screen
2.53 USD
Price as of 22 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-22 · the tape above runs as of 18:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price2.53 USD at the 22 Oct 2026 close
Ethical screenDoes not pass
Last reviewed22 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 2.53 against the desk's fair-value range, over the last year.
Positioning no disclosures inside 60 days, left as found
Options no verdict drawn today, left as found
Ethical does not pass the values gate
Price2.53 USD
Ethical score70.0/100
Our investment reviews on this name
2026-10-21Read Distribution2.82-10.3% to today ✓Markup gives way to Distribution first Distribution read since October
2026-10-14Read Markup2.91-13.2% to today Distribution gives way to Markup after an 18% rise in 12 days
2026-10-02Read Distribution2.46+2.8% to today Markup gives way to Distribution after a 390% rise in 13 weeks
2026-07-02Read Markup0.50+403.5% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Hitek Global Inc holds its Distribution at $2.53. Consolidating, no directional conviction, held for 46 days.
As held on the ledger · 2026-10-22
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 46 days
Price at the screen
$2.53
Valuation
0.03 trailing · N/A forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.15
The Workings
Five Screens, Shown in Full
Does not pass. Interest-bearing securities
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
6.21%
Below 33%
Interest-bearing debt is just 6.2% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
42.38%
Below 33%
Interest-bearing cash and securities are 42.4% of assets, above the one-third limit.
Fail
Receivables
21.18%
Below 49%
Money owed to the company is 21.2% of assets, under the 49% limit.
Pass
Revenue purity
12.90%
Below 5%
12.9% of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Hitek Global's business is fine, but its cash and interest-bearing securities are about 42% of its assets, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HKIT's ethical verdict changes
Today HKIT does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to China and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
HKIT trades on NASDAQ (the company is based in China). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-21Distribution · changed$2.82-3.3%Entry 8
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 3.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-10-14Markup · changed$2.91+18.5%Entry 7
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 18.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 26.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-09-01Markup$3.36+0.0%Entry 5
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-08-01Markup$3.36+568.7%Entry 4
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 568.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-07-18Markup$0.50+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 100%. Our forward projection puts the odds of a 10% gain over the next month near 16%.
2026-07-03Markup$0.50+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
2026-07-02Markup$0.50Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.